Related references
Note: Only part of the references are listed.Efficacy of Tocilizumab in Management of COVID-19 Patients Admitted to Intensive Care Units: A Multicenter Retrospective Cohort Study
Hoda Younes Ibrahem et al.
MEDICINA-LITHUANIA (2023)
Serological response to the BNT162b2 mRNA or ChAdOx1 nCoV-19 COVID-19 vaccine after first and second doses in patients with plasma cell disorders: influence of host and disease factors
Wei Yee Chan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2022)
Incidence and outcome of SARS-CoV-2 infection in patients with monoclonal gammopathy of undetermined significance: a case-control study
Nicola Sgherza et al.
HAEMATOLOGICA (2022)
Neutralizing Antibody Testing in Patients With Multiple Myeloma Following COVID-19 Vaccination
Evangelos Terpos et al.
JAMA ONCOLOGY (2022)
SARS-CoV-2 Infection Incidence and Outcome Before and After Full Vaccination in Patients With Monoclonal Gammopathy of Undetermined Significance
Nicola Sgherza et al.
HEMASPHERE (2022)
Impact of COVID-19 in patients with multiple myeloma based on a global data network
J. Martinez-Lopez et al.
BLOOD CANCER JOURNAL (2021)
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2021)
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
David S. Khoury et al.
NATURE MEDICINE (2021)
Outcome of COVID-19 infection in 50 multiple myeloma patients treated with novel drugs: single-center experience
Marta Krejci et al.
ANNALS OF HEMATOLOGY (2021)
Highly variable SARS-CoV-2 spike antibody responses to two doses of COVID-19 RNA vaccination in patients with multiple myeloma
Oliver Van Oekelen et al.
CANCER CELL (2021)
Response to mRNA vaccination for COVID-19 among patients with multiple myeloma
Samuel D. Stampfer et al.
LEUKEMIA (2021)
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment
Evangelos Terpos et al.
BLOOD CANCER JOURNAL (2021)
Using Machine Learning Algorithms to Develop a Clinical Decision-Making Tool for COVID-19 Inpatients
Abhinav Vepa et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Real-world assessment of the clinical impact of symptomatic infection with severe acute respiratory syndrome coronavirus (COVID-19 disease) in patients with multiple myeloma receiving systemic anti-cancer therapy
Gordon Cook et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
A tertiary center experience of multiple myeloma patients with COVID-19: lessons learned and the path forward
Bo Wang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Clinical features associated with COVID-19 outcome in multiple myeloma: first results from the International Myeloma Society data set
Ajai Chari et al.
BLOOD (2020)
Predictors of intensive care unit admission in patients with hematologic malignancy
Abi Vijenthira et al.
SCIENTIFIC REPORTS (2020)
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Oksana Zavidij et al.
NATURE CANCER (2020)
Comparative Study of Immune Status to Infectious Agents in Elderly Patients with Multiple Myeloma, Waldenstrom's Macroglobulinemia, and Monoclonal Gammopathy of Undetermined Significance
Johanna Karlsson et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)